Brentuximab is an advanced medication prescribed world over for the treatment of Haematological Malignancies including refractory Hodgkin lymphoma (HL) and systemic Anaplastic Large Cell Lymphoma (ALCL). The trade name of…
Vemurafenib in India and the therapeutic benefits
Vemurafenib is FDA approved and a drug of choice for metastatic melanoma and Erdheim-Chester Disease (ECD). On specific recommendations, Zelboraf is advised patients with BRAF V600 mutation. Being an advanced…
Access to Ponatinib in India in the context of therapeutic recommendations of Iclusig
Ponatinib, an oral medication available in tablets form is advised by Hematologists from various regions of the world. It is approved and therefore recommended in the management of Chronic Myeloid…